Literature DB >> 31179484

Cryptococcal Antigen Screening and Preemptive Treatment-How Can We Improve Survival?

Radha Rajasingham1, David R Boulware1.   

Abstract

Keywords:  AIDS; Cryptococcus; HIV; cryptococcal meningitis; screening

Year:  2020        PMID： 31179484      PMCID： PMC7145997          DOI： 10.1093/cid/ciz488

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  17 in total

1.  Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings.

Authors:  David B Meya; Yukari C Manabe; Barbara Castelnuovo; Bethany A Cook; Ali M Elbireer; Andrew Kambugu; Moses R Kamya; Paul R Bohjanen; David R Boulware
Journal:  Clin Infect Dis       Date:  2010-08-15       Impact factor: 9.079

2.  Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus-associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled Trial.

Authors:  Joseph N Jarvis; Tshepo B Leeme; Mooketsi Molefi; Awilly A Chofle; Gabriella Bidwell; Katlego Tsholo; Nametso Tlhako; Norah Mawoko; Raju K K Patel; Mark W Tenforde; Charles Muthoga; Gregory P Bisson; Jeremiah Kidola; John Changalucha; David Lawrence; Shabbar Jaffar; William Hope; Si le F Molloy; Thomas S Harrison
Journal:  Clin Infect Dis       Date:  2019-01-18       Impact factor: 9.079

3.  Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.

Authors:  Radha Rajasingham; Rachel M Smith; Benjamin J Park; Joseph N Jarvis; Nelesh P Govender; Tom M Chiller; David W Denning; Angela Loyse; David R Boulware
Journal:  Lancet Infect Dis       Date:  2017-05-05       Impact factor: 25.071

4.  A Prospective Evaluation of a Multisite Cryptococcal Screening and Treatment Program in HIV Clinics in Uganda.

Authors:  Elizabeth Nalintya; David B Meya; Sarah Lofgren; Kathy Huppler Hullsiek; David R Boulware; Radha Rajasingham
Journal:  J Acquir Immune Defic Syndr       Date:  2018-06-01       Impact factor: 3.731

5.  Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012.

Authors:  Jennie McKenney; Sean Bauman; Brandon Neary; Roger Detels; Audrey French; Joseph Margolick; Brian Doherty; Jeffrey D Klausner
Journal:  Clin Infect Dis       Date:  2014-11-24       Impact factor: 9.079

6.  Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial.

Authors:  Sayoki Mfinanga; Duncan Chanda; Sokoine L Kivuyo; Lorna Guinness; Christian Bottomley; Victoria Simms; Carol Chijoka; Ayubu Masasi; Godfather Kimaro; Bernard Ngowi; Amos Kahwa; Peter Mwaba; Thomas S Harrison; Saidi Egwaga; Shabbar Jaffar
Journal:  Lancet       Date:  2015-03-10       Impact factor: 79.321

Review 7.  Cryptococcal Meningitis Diagnostics and Screening in the Era of Point-of-Care Laboratory Testing.

Authors:  Radha Rajasingham; Rachel M Wake; Tafese Beyene; Andrew Katende; Emilio Letang; David R Boulware
Journal:  J Clin Microbiol       Date:  2019-01-02       Impact factor: 5.948

8.  Symptomatic Cryptococcal Antigenemia Presenting as Early Cryptococcal Meningitis With Negative Cerebral Spinal Fluid Analysis.

Authors:  Kenneth Ssebambulidde; Ananta S Bangdiwala; Richard Kwizera; Tadeo Kiiza Kandole; Lillian Tugume; Reuben Kiggundu; Edward Mpoza; Edwin Nuwagira; Darlisha A Williams; Sarah M Lofgren; Mahsa Abassi; Abdu K Musubire; Fiona V Cresswell; Joshua Rhein; Conrad Muzoora; Kathy Huppler Hullsiek; David R Boulware; David B Meya
Journal:  Clin Infect Dis       Date:  2019-05-30       Impact factor: 9.079

9.  Laboratory-Reflex Cryptococcal Antigen Screening Is Associated With a Survival Benefit in Tanzania.

Authors:  Diana Faini; Aneth Vedastus Kalinjuma; Andrew Katende; Gladys Mbwaji; Dorcas Mnzava; Amina Nyuri; Tracy R Glass; Hansjakob Furrer; Christoph Hatz; David R Boulware; Emilio Letang
Journal:  J Acquir Immune Defic Syndr       Date:  2019-02-01       Impact factor: 3.731

10.  Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial.

Authors:  David B Meya; Agnes N Kiragga; Elizabeth Nalintya; Bozena M Morawski; Radha Rajasingham; Benjamin J Park; Anthony Mubiru; Jonathan E Kaplan; Yukari C Manabe; David R Boulware
Journal:  J Acquir Immune Defic Syndr       Date:  2019-02-01       Impact factor: 3.731
View more
  6 in total

1.  Evaluation of Serum Cryptococcal Antigen Testing Using Two Novel Semiquantitative Lateral Flow Assays in Persons with Cryptococcal Antigenemia.

Authors:  Caleb Skipper; Kiiza Tadeo; Emily Martyn; Elizabeth Nalintya; Radha Rajasingham; David B Meya; Bosco Kafufu; Joshua Rhein; David R Boulware
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

2.  Potential missed opportunities for diagnosis of cryptococcosis and the association with mortality: A cohort study.

Authors:  Ana S Salazar; Matthew R Keller; Margaret A Olsen; Katelin B Nickel; Ige A George; Lindsey Larson; William G Powderly; Andrej Spec
Journal:  EClinicalMedicine       Date:  2020-10-07

3.  Benefits of enhanced infection prophylaxis at antiretroviral therapy initiation by cryptococcal antigen status.

Authors:  Sarah L Pett; Moira Spyer; Lewis J Haddow; Ruth Nhema; Laura A Benjamin; Grace Najjuka; Sithembile Bilima; Ibrahim Daud; Godfrey Musoro; Juliet Kitabalwa; George Selemani; Salome Kandie; K Magut Cornelius; Chrispus Katemba; Jay A Berkley; Amin S Hassan; Cissy Kityo; James Hakim; Robert S Heyderman; Diana M Gibb; Ann S Walker
Journal:  AIDS       Date:  2021-03-15       Impact factor: 4.632

Review 4.  Diagnosis and Management of Central Nervous System Cryptococcal Infections in HIV-Infected Adults.

Authors:  Caleb Skipper; Mahsa Abassi; David R Boulware
Journal:  J Fungi (Basel)       Date:  2019-07-19

5.  Baseline Serum C-Reactive Protein Level Predicts Mortality in Cryptococcal Meningitis.

Authors:  Supavit Chesdachai; Nicole W Engen; Joshua Rhein; Lillian Tugume; Tadeo Kiiza Kandole; Mahsa Abassi; Kenneth Ssebambulidde; John Kasibante; Darlisha A Williams; Caleb P Skipper; Kathy H Hullsiek; Abdu K Musubire; Radha Rajasingham; David B Meya; David R Boulware
Journal:  Open Forum Infect Dis       Date:  2020-10-29       Impact factor: 3.835

Review 6.  Fungal CNS Infections in Africa: The Neuroimmunology of Cryptococcal Meningitis.

Authors:  Sally H Mohamed; Tinashe K Nyazika; Kenneth Ssebambulidde; Michail S Lionakis; David B Meya; Rebecca A Drummond
Journal:  Front Immunol       Date:  2022-04-01       Impact factor: 8.786
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.